A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion

References

• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241 - 52; http://dx.doi.org/10.1056/NEJMra035010; PMID: 14657432
   PubMed Web of Science ®Google Scholar
• Okano J, Snyder L, Rustgi AK. Genetic alterations in esophageal cancer. Methods Mol Biol 2003; 222:131 - 45; PMID: 12710684
   PubMedGoogle Scholar
• Rustgi AK. Models of esophageal carcinogenesis. Semin Oncol 2006; 33:Suppl 11 S57 - 8; http://dx.doi.org/10.1053/j.seminoncol.2006.10.013; PMID: 17178289
   PubMed Web of Science ®Google Scholar
• Lehrbach DM, Nita ME, Cecconello I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol 2003; 40:256 - 61; http://dx.doi.org/10.1590/S0004-28032003000400011; PMID: 15264049
   PubMedGoogle Scholar
• Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, et al. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev 2007; 21:2788 - 803; http://dx.doi.org/10.1101/gad.1544507; PMID: 17974918
   PubMed Web of Science ®Google Scholar
• Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994; 74:795 - 804; http://dx.doi.org/10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; PMID: 8039107
   PubMed Web of Science ®Google Scholar
• Parenti AR, Rugge M, Frizzera E, Ruol A, Noventa F, Ancona E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 1995; 19:1418 - 22; http://dx.doi.org/10.1097/00000478-199512000-00008; PMID: 7503363
   PubMed Web of Science ®Google Scholar
• Volant A, Nousbaum JB, Giroux MA, Roué-Quintin I, Metges JP, Férec C, et al. p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol 1995; 48:531 - 4; http://dx.doi.org/10.1136/jcp.48.6.531; PMID: 7665695
   PubMed Web of Science ®Google Scholar
• Alsner J, Sørensen SB, Overgaard J. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother Oncol 2001; 59:179 - 85; http://dx.doi.org/10.1016/S0167-8140(01)00301-2; PMID: 11325447
   PubMed Web of Science ®Google Scholar
• Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007; 357:2552 - 61; http://dx.doi.org/10.1056/NEJMoa073770; PMID: 18094376
   PubMed Web of Science ®Google Scholar
• Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847 - 60; http://dx.doi.org/10.1016/j.cell.2004.11.004; PMID: 15607980
   PubMed Web of Science ®Google Scholar
• Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004; 119:861 - 72; http://dx.doi.org/10.1016/j.cell.2004.11.006; PMID: 15607981
   PubMed Web of Science ®Google Scholar
• Comoglio PM, Trusolino L. Invasive growth: from development to metastasis. J Clin Invest 2002; 109:857 - 62; PMID: 11927611
   PubMed Web of Science ®Google Scholar
• Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7:504 - 16; http://dx.doi.org/10.1038/nrd2530; PMID: 18511928
   PubMed Web of Science ®Google Scholar
• Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11:834 - 48; http://dx.doi.org/10.1038/nrm3012; PMID: 21102609
   PubMed Web of Science ®Google Scholar
• Knudsen BS, Vande Woude G. Showering c-MET-dependent cancers with drugs. Curr Opin Genet Dev 2008; 18:87 - 96; http://dx.doi.org/10.1016/j.gde.2008.02.001; PMID: 18406132
   PubMed Web of Science ®Google Scholar
• Joffre C, Barrow R, Ménard L, Calleja V, Hart IR, Kermorgant S. A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol 2011; 13:827 - 37; http://dx.doi.org/10.1038/ncb2257; PMID: 21642981
   PubMed Web of Science ®Google Scholar
• Rong S, Donehower LA, Hansen MF, Strong L, Tainsky M, Jeffers M, et al. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res 1995; 55:1963 - 70; PMID: 7728766
   PubMed Web of Science ®Google Scholar
• Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A 2011; 108:14240 - 5; http://dx.doi.org/10.1073/pnas.1017536108; PMID: 21831840
   PubMed Web of Science ®Google Scholar
• Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci U S A 2010; 107:11026 - 31; http://dx.doi.org/10.1073/pnas.0914295107; PMID: 20534479
   PubMed Web of Science ®Google Scholar
• Accornero P, Miretti S, Cucuzza LS, Martignani E, Baratta M. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells. J Mol Endocrinol 2010; 44:115 - 25; http://dx.doi.org/10.1677/JME-09-0035; PMID: 19850646
   PubMed Web of Science ®Google Scholar
• Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors. Lancet Oncol 2009; 10:709 - 17; http://dx.doi.org/10.1016/S1470-2045(09)70137-8; PMID: 19573800
   PubMed Web of Science ®Google Scholar
• Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem 2000; 275:8806 - 11; http://dx.doi.org/10.1074/jbc.275.12.8806; PMID: 10722725
   PubMed Web of Science ®Google Scholar
• Martínez-Palacián A, del Castillo G, Herrera B, Fernández M, Roncero C, Fabregat I, et al. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells. Cell Signal 2012; 24:505 - 13; http://dx.doi.org/10.1016/j.cellsig.2011.09.031; PMID: 22001397
   PubMed Web of Science ®Google Scholar
• Michaylira CZ, Wong GS, Miller CG, Gutierrez CM, Nakagawa H, Hammond R, et al. Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Res 2010; 70:5281 - 92; http://dx.doi.org/10.1158/0008-5472.CAN-10-0704; PMID: 20516120
   PubMed Web of Science ®Google Scholar
• Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 2003; 278:1824 - 30; http://dx.doi.org/10.1074/jbc.M209148200; PMID: 12435727
   PubMed Web of Science ®Google Scholar
• Wang W, Kim SH, El-Deiry WS. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. Proc Natl Acad Sci U S A 2006; 103:11003 - 8; http://dx.doi.org/10.1073/pnas.0604507103; PMID: 16835297
   PubMed Web of Science ®Google Scholar
• Lambert JM, Gorzov P, Veprintsev DB, Söderqvist M, Segerbäck D, Bergman J, et al. PRIMA-1 reactivates mutant p53 by covalent binding to the core domain. Cancer Cell 2009; 15:376 - 88; http://dx.doi.org/10.1016/j.ccr.2009.03.003; PMID: 19411067
   PubMed Web of Science ®Google Scholar
• Wischhusen J, Naumann U, Ohgaki H, Rastinejad F, Weller M. CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 2003; 22:8233 - 45; http://dx.doi.org/10.1038/sj.onc.1207198; PMID: 14614447
   PubMed Web of Science ®Google Scholar
• Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009; 139:1327 - 41; http://dx.doi.org/10.1016/j.cell.2009.11.026; PMID: 20064378
   PubMed Web of Science ®Google Scholar
• Muller PA, Trinidad AG, Timpson P, Morton JP, Zanivan S, van den Berghe PV, et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene 2013; 32:1252 - 65; http://dx.doi.org/10.1038/onc.2012.148; PMID: 22580601
   PubMed Web of Science ®Google Scholar
• Lu X, Liu DP, Xu Y. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis. Oncogene 2012; PMID: 22824795
   PubMed Web of Science ®Google Scholar
• Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, et al. MicroRNAs impair MET-mediated invasive growth. Cancer Res 2008; 68:10128 - 36; http://dx.doi.org/10.1158/0008-5472.CAN-08-2148; PMID: 19074879
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447:1130 - 4; http://dx.doi.org/10.1038/nature05939; PMID: 17554337
   PubMed Web of Science ®Google Scholar
• Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T, et al. Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer. Clin Cancer Res 2013; 19:710 - 20; http://dx.doi.org/10.1158/1078-0432.CCR-12-1703; PMID: 23243217
   PubMed Web of Science ®Google Scholar
• Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M, et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006; 12:62 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-05-0413; PMID: 16397025
   PubMed Web of Science ®Google Scholar
• Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003; 1:729 - 38; PMID: 12939398
   PubMed Web of Science ®Google Scholar
• Takaoka M, Harada H, Deramaudt TB, Oyama K, Andl CD, Johnstone CN, et al. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction. Oncogene 2004; 23:6760 - 8; http://dx.doi.org/10.1038/sj.onc.1207923; PMID: 15273725
   PubMed Web of Science ®Google Scholar
• Kalabis J, Wong GS, Vega ME, Natsuizaka M, Robertson ES, Herlyn M, et al. Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture. Nat Protoc 2012; 7:235 - 46; http://dx.doi.org/10.1038/nprot.2011.437; PMID: 22240585
   PubMed Web of Science ®Google Scholar